Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Sherise D Ferguson
Affiliation
The University of Texas MD Anderson Cancer Center
ORCID
Career Start Year
2005
Papers
70
H Index
26
Expertise
CM4AI Collaborator
PMID
Paper Title
Journal Title
Published Year
37622466
Leptomeningeal disease in melanoma: An update on the developments in pathophysiology and clinical care.
Pigment Cell Melanoma Res
2024
36510640
Changes in outcomes and factors associated with survival in melanoma patients with brain metastases.
Neuro Oncol
2023
37944358
Subependymomas of the fourth ventricle: To operate or not to operate?
J Clin Neurosci
2023
37295724
Postoperative Management of Recurrence After Radiosurgery and Surgical Resection for Brain Metastases and Predicting Benefit From Adjuvant Radiation.
Pract Radiat Oncol
2023
36997799
Concurrent intrathecal and intravenous nivolumab in leptomeningeal disease: phase 1 trial interim results.
Nat Med
2023
35053503
TMS Seeded Diffusion Tensor Imaging Tractography Predicts Permanent Neurological Deficits.
Cancers (Basel)
2022
35396789
Cerebrovascular Reactivity Mapping Using Resting-State Functional MRI in Patients With Gliomas.
J Magn Reson Imaging
2022
35359380
Surgical Management of Brain Metastasis: Challenges and Nuances.
Front Oncol
2022
36299565
Automated Brain Metastases Segmentation With a Deep Dive Into False-positive Detection.
Adv Radiat Oncol
2022
35912544
Melanoma central nervous system metastases: An update to approaches, challenges, and opportunities.
Pigment Cell Melanoma Res
2022
35316217
Central nervous system immune interactome is a function of cancer lineage, tumor microenvironment, and STAT3 expression.
JCI Insight
2022
35096602
Challenges and Advances in Diagnosis and Treatment of Leptomeningeal Disease (LMD).
Front Oncol
2022
35059999
Advances in Diagnosis and Treatment for Leptomeningeal Disease in Melanoma.
Curr Oncol Rep
2022
34996044
Circumferential sulcus-guided resection technique for improved outcomes of low-grade gliomas.
J Neurosurg
2022
35083579
Long term outcomes following surgery for pineal region tumors.
J Neurooncol
2022
33080024
Alterations in Functional Connectomics Associated With Neurocognitive Changes Following Glioma Resection.
Neurosurgery
2021
33931525
Pearls & Oy-sters: Primary Pineal Melanoma With Leptomeningeal Carcinomatosis.
Neurology
2021
34691054
CD11c+CD163+ Cells and Signal Transducer and Activator of Transcription 3 (STAT3) Expression Are Common in Melanoma Leptomeningeal Disease.
Front Immunol
2021
30799490
Perilesional Resection of Glioblastoma Is Independently Associated With Improved Outcomes.
Neurosurgery
2020
31755915
Window-of-opportunity clinical trial of pembrolizumab in patients with recurrent glioblastoma reveals predominance of immune-suppressive macrophages.
Neuro Oncol
2020
31990608
Cumulative Incidence and Predictors of CNS Metastasis for Patients With American Joint Committee on Cancer 8th Edition Stage III Melanoma.
J Clin Oncol
2020
31793025
Presurgical resting-state functional MRI language mapping with seed selection guided by regional homogeneity.
Magn Reson Med
2020
33426529
A validated integrated clinical and molecular glioblastoma long-term survival-predictive nomogram.
Neurooncol Adv
2020
32653026
The role of resting-state functional MRI for clinical preoperative language mapping.
Cancer Imaging
2020
32921358
Targeting the Tumor Microenvironment in Brain Metastasis.
Neurosurg Clin N Am
2020
32721947
Profiling of patients with glioma reveals the dominant immunosuppressive axis is refractory to immune function restoration.
JCI Insight
2020
32407910
Association Between Facility Volume and Overall Survival for Patients with Grade II Meningioma after Gross Total Resection.
World Neurosurg
2020
30641236
National Patterns of Care in the Management of World Health Organization Grade II and III Spinal Ependymomas.
World Neurosurg
2019
30847840
Predictors of survival in metastatic melanoma patients with leptomeningeal disease (LMD).
J Neurooncol
2019
30787016
Molecular Profiling Reveals Unique Immune and Metabolic Features of Melanoma Brain Metastases.
Cancer Discov
2019
29241173
Surgical Management of Gliomas in Eloquent Cortex.
Prog Neurol Surg
2018
29923182
Profiles of brain metastases: Prioritization of therapeutic targets.
Int J Cancer
2018
28409732
The surgical treatment of tumors of the fourth ventricle: a single-institution experience.
J Neurosurg
2018
29718398
Targetable Gene Fusions Associate With the IDH Wild-Type Astrocytic Lineage in Adult Gliomas.
J Neuropathol Exp Neurol
2018
29541912
Correction to: A predictive model for distinguishing radiation necrosis from tumour progression after gamma knife radiosurgery based on radiomic features from MR images.
Eur Radiol
2018
29593520
IClinfMRI Software for Integrating Functional MRI Techniques in Presurgical Mapping and Clinical Studies.
Front Neuroinform
2018
29178031
A predictive model for distinguishing radiation necrosis from tumour progression after gamma knife radiosurgery based on radiomic features from MR images.
Eur Radiol
2018
29241177
Surgical Management of Recurrent Intracranial Gliomas.
Prog Neurol Surg
2018
28687375
Post-operative stereotactic radiosurgery versus observation for completely resected brain metastases: a single-centre, randomised, controlled, phase 3 trial.
Lancet Oncol
2017
28389997
Tumor Vaccines for Malignant Gliomas.
Neurotherapeutics
2017
29487694
Ependymomas overexpress chemoresistance and DNA repair-related proteins.
Oncotarget
2017
28965270
Neurosurgical management of brain metastases.
Clin Exp Metastasis
2017
28528423
Rapid resolution of leptomeningeal disease with targeted therapy in a metastatic melanoma patient.
J Neurooncol
2017
26973123
Cytomegalovirus-targeted immunotherapy and glioblastoma: hype or hope?
Immunotherapy
2016
26488329
Gamma Knife Stereotactic Radiosurgery for Brain Metastases Using Only 3 Pins.
Neurosurgery
2016
27471611
Prioritization schema for immunotherapy clinical trials in glioblastoma.
Oncoimmunology
2016
27225028
Immunotherapy in glioblastoma: emerging options in precision medicine.
CNS Oncol
2016
27579614
GBM-associated mutations and altered protein expression are more common in young patients.
Oncotarget
2016
25503249
Fatal juvenile xanthogranuloma presenting as a sellar lesion: case report and literature review.
Childs Nerv Syst
2015
26122381
Patient and treatment factors associated with survival among adult glioblastoma patients: A USA population-based study from 2000-2010.
J Clin Neurosci
2015
1 - 50 of 70
Column Actions
Search
Recommended Authors
Nancy Wang
Massachusetts General Hospital Cancer Center, Harvard Medical School
Career Start Year
2013
Number of shared co-authors
1
Farshad Nassiri
Toronto Western Hospital, University Health Network, University of Toronto
Career Start Year
2010
Number of shared co-authors
6
Rohan Ramakrishna
Weill Cornell Medical College, New York Presbyterian Hospital
Career Start Year
2009
Number of shared co-authors
7
Maryam Rahman
University of Florida
Career Start Year
2008
Number of shared co-authors
1
Yoshua Esquenazi
McGovern Medical School at UT Health Houston
Career Start Year
2007
Number of shared co-authors
2
Nicholas Butowski
University of California san francisco
Career Start Year
2005
Number of shared co-authors
6
Analiz Rodriguez
University of Arkansas for Medical Sciences
Career Start Year
2004
Number of shared co-authors
5
Gelareh Zadeh
University of Toronto
Career Start Year
2003
Number of shared co-authors
14
Matthias Preusser
Medical University of Vienna
Career Start Year
2003
Number of shared co-authors
6
Martin Glas
University Hospital Essen
Career Start Year
2002
Number of shared co-authors
0
Andrew P Morokoff
Clinical Sciences Building, The University of Melbourne, The Royal Melbourne Hospital
Career Start Year
2001
Number of shared co-authors
0
Mariza Daras
University of California san francisco
Career Start Year
2001
Number of shared co-authors
6
Chul-Kee Park
College of Medicine, Seoul National University
Career Start Year
2000
Number of shared co-authors
4
Ghazaleh Tabatabai
University Hospital Tubingen, Eberhard-Karls-University Tubingen
Career Start Year
1998
Number of shared co-authors
6
John A Boockvar
Lenox Hill Hospital
Career Start Year
1997
Number of shared co-authors
1
Manish K Aghi
University of California san francisco
Career Start Year
1997
Number of shared co-authors
4
Martin Hunn
0The Alfred Hospital
Career Start Year
1997
Number of shared co-authors
0
Vinay K Puduvalli
The University of Texas MD Anderson Cancer Center
Career Start Year
1996
Number of shared co-authors
17
Tracy T Batchelor
Brigham and Women's Hospital
Career Start Year
1996
Number of shared co-authors
10
Warren P Mason
Princess Margaret Cancer Centre
Career Start Year
1996
Number of shared co-authors
8
Do-Hyun Nam
Samsung Medical Center, Sungkyunkwan University School
Career Start Year
1996
Number of shared co-authors
12
Clark C Chen
University of Minnesota
Career Start Year
1994
Number of shared co-authors
8
Ho-Shin Gwak
National Cancer Center
Career Start Year
1994
Number of shared co-authors
2
Tom Mikkelsen
Ontario Brain Institute
Career Start Year
1990
Number of shared co-authors
17
Howard Colman
Huntsman Cancer Institute, University of Utah
Career Start Year
1990
Number of shared co-authors
25
Camilo E Fadul
University of Virginia Health System
Career Start Year
1987
Number of shared co-authors
1
Ryo Nishikawa
Saitama Medical University International Medical Center
Career Start Year
1986
Number of shared co-authors
5
Michael A Vogelbaum
Moffit Cancer Center
Career Start Year
1986
Number of shared co-authors
10
Robert Aiken
Rutgers Cancer Institute of New Jersey, Rutgers University
Career Start Year
1984
Number of shared co-authors
5
David Schiff
University of Virginia School of Medicine
Career Start Year
1966
Number of shared co-authors
10
row(s) 1 - 30 of 30
Collaborators
Amy B Heimberger
Northwestern University Feinberg School of Medicine
Co-authored papers
21
Ian E McCutcheon
The University of Texas M.D. Anderson Cancer Center
Co-authored papers
13
Raymond Sawaya
The University of Texas M.D. Anderson Cancer Center, American University of Beirut
Co-authored papers
11
Frederick F Lang
The University of Texas M.D. Anderson Cancer Center
Co-authored papers
10
Ganesh Rao
The University of Texas M.D. Anderson Cancer Center
Co-authored papers
10
Gregory N Fuller
MD Anderson Cancer Center
Co-authored papers
9
Michael A Davies
The University of Texas MD Anderson Cancer Center
Co-authored papers
8
Jason T Huse
Co-authored papers
7
John F de Groot
Co-authored papers
6
Hussein A Tawbi
MD Anderson Cancer Center
Co-authored papers
6
Joanne Xiu
Co-authored papers
5
Roel G W Verhaak
Yale School of Medicine
Co-authored papers
4
Jeffrey E Gershenwald
The University of Texas MD Anderson Cancer Center
Co-authored papers
4
Ling-Yuan Kong
The University of Texas MD Anderson Cancer Center
Co-authored papers
4
Rivka R Colen
Co-authored papers
4
David Spetzler
Co-authored papers
4
Priscilla K Brastianos
Co-authored papers
3
Jinzhong Yang
University of Texas MD Anderson Cancer Center
Co-authored papers
3
Jun Wei
The University of Texas MD Anderson Cancer Center
Co-authored papers
3
Laurence E Court
The University of Texas MD Anderson Cancer Center
Co-authored papers
3
Jennifer A Wargo
Co-authored papers
3
Lifei Zhang
The University of Texas MD Anderson Cancer Center.
Co-authored papers
2
Tiffany Doucette
Baylor College of Medicine, The University of Texas MD Anderson Cancer Center
Co-authored papers
2
Waldemar Priebe
The University of Texas MD Anderson Cancer Center
Co-authored papers
2
Qingyi Wei
South China University of Technology
Co-authored papers
2
Craig Horbinski
Co-authored papers
2
Yuhui Yang
Xuanwu Hospital, Capital Medical University
Co-authored papers
2
Wai-Kwan Alfred Yung
University of Texas M.D. Anderson Cancer Center
Co-authored papers
2
Alexander J Lazar
The University of Texas MD Anderson Cancer Center
Co-authored papers
2
Jianjun Zhang
The University of Texas MD Anderson Cancer Center
Co-authored papers
2
1 - 30